US3805767A - Method and apparatus for non-surgical, reversible sterilization of females - Google Patents

Method and apparatus for non-surgical, reversible sterilization of females Download PDF

Info

Publication number
US3805767A
US3805767A US00335816A US33581673A US3805767A US 3805767 A US3805767 A US 3805767A US 00335816 A US00335816 A US 00335816A US 33581673 A US33581673 A US 33581673A US 3805767 A US3805767 A US 3805767A
Authority
US
United States
Prior art keywords
oviduct
tip
tip member
terminal end
block
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00335816A
Inventor
R Erb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Franklin Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US00335816A priority Critical patent/US3805767A/en
Priority to ZA740931A priority patent/ZA74931B/en
Priority to IL44203A priority patent/IL44203A/en
Priority to DE19742407652 priority patent/DE2407652C3/en
Priority to GB825174A priority patent/GB1430045A/en
Priority to SE7402428A priority patent/SE419698B/en
Priority to BR741387A priority patent/BR7401387D0/en
Priority to JP49022743A priority patent/JPS5239595B2/ja
Priority to NL747402502A priority patent/NL154660B/en
Priority to BE141359A priority patent/BE811539A/en
Priority to IT48696/74A priority patent/IT1015818B/en
Priority to CA193,336A priority patent/CA1046372A/en
Priority to FR7406289A priority patent/FR2218907B1/fr
Priority to AU66031/74A priority patent/AU465515B2/en
Priority to CH270874A priority patent/CH578876A5/xx
Application granted granted Critical
Publication of US3805767A publication Critical patent/US3805767A/en
Priority to US05/679,185 priority patent/USRE29345E/en
Priority to CA313,134A priority patent/CA1062110A/en
Assigned to CALSPAN CORPORATION reassignment CALSPAN CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: FRANKLIN INSTITUTE
Assigned to FRANKLIN INSTITUTE reassignment FRANKLIN INSTITUTE ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: CALSPAN CORPORATION, AN OH CORP.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/20Vas deferens occluders; Fallopian occluders
    • A61F6/22Vas deferens occluders; Fallopian occluders implantable in tubes
    • A61F6/225Vas deferens occluders; Fallopian occluders implantable in tubes transcervical

Definitions

  • the tip is, aligned with the uterine end of the oviduct.
  • a curable elastomeric composition is injected, through an aperture in the tip, into the oviduct in an amount sufficient to fill the portion of the oviduct adjacent to the uterus.
  • the elastomeric composition is allowed to solidify and adhere to the above noted tip.
  • the apparatus is then removed with the tip being ejected from the apparatus so as to remain adhered to the resulting oviduct block.
  • the above procedure is repeated. for the opposite oviduct.
  • the resulting oviduct blocks prevent the passage of ovum from the ovaries to the uterus and sperm from entering'the oviduct thereby preventing conception.
  • the oviduct blocks if desired can be removed non-surgically by utilizing an apparatus whichgrips the tip portion of the oviduct block and extracts the entire oviduct block from the oviduct.
  • the ideal contraception method should be 100 percent effective in preventing conception; should not rely on willpower; should not interfere with the satisfaction of sexual relationships, and should be low in cost taking into consideration the effective life of the contraceptive method.
  • the contraceptive method must not have any harmful psychological side effects.
  • An extremely important feature of an ideal contraceptive method especially for family planning is that it be reversible so that it will be possible to have additional children if desired.
  • a method and apparatus is provided to form oviduct blocks which prevent conception when in place and can be nonsurgically removed if desires.
  • the apparatus is inserted through the cervical os into the uterus.
  • the tip on the apparatus is then aligned with the uterine end of the oviduct.
  • a mixture of a fluid elastomeric material and a catalyst for polymerizing the elastomeric mixture is injected through an aperture in the tip into the oviduct.
  • the elastomeric material is allowed to solidify and to adhere to the tip.
  • the tip is released so that it remains with the injected elastomeric material to form the oviduct block of this invention.
  • the apparatus is then removed.
  • the oviduct block can be removed nonsurgically by inserting an instrument into the uterus through the cervix which grips the tip of the oviduct block and then withdrawing the oviduct block which restores normal fertility.
  • FIG. 1 is an illustration in partial cross-section of an apparatus especially adopted for use in the method of this invention.
  • FIG. 2 is an illustration in partial cross-section of a uterus, the cervix and a portion of the vagina.
  • the uterus is illustrated with an oviduct block insert in one of the oviduct and the terminal end of the apparatus of FIG. 1 positioned for insertion of an oviduct block into the opposite oviduct.
  • FIG. 3 is an enlarged illustration taken in partial cross-section of the terminal end of the apparatus of FIG. 1.
  • FIG. 4 is an illustration in cross-section of the terminal end of the apparatus of FIG. 3 shown with fluid uncured elastomeric material shown in the internal feed tube.
  • FIG. 5 is an illustration shown in cross-section showing the separation of the tip from the apparatus of FIG. 1.
  • an oviduct block is formed in situ in the oviduct.
  • the oviduct block is most preferable formed from a medical inert plastic which has approximately the same modulus of elasticity as the oviduct.
  • the selection of material having the proper modulus of elasticity appears to both' prevent cxplusion of the oviduct block and substantially eliminates any physical discomfort.
  • the materials which have been found most useful in the method of this invention are the commercially available medical grade silicone elastomers.
  • the uncured silicone elastomer in the fluid state is blended with a catalyst for solidifying the elastomer and a dilution fluid to control the viscosity during injection and also to control the modulus of elasticity of the cured solidified material. It is preferable to also include a radiopaque material in the mixture to facilitate the placement of the oviduct block and to facilitate removal of the oviduct block if desires.
  • a tip is molded from an inert plastic material to which the injected elastomeric material will adhere on solidification.
  • silicone-rubber is ideally suited for this purpose when a silicone elastomer is used for formation of the oviduct block.
  • the portion of the tip 10 which will be in contact with uterine end of the oviduct 12 has a spherical configuration.
  • the tip 10 has an aperture 14 which extends throughout the entire length of the tip 14.
  • the tip as illustrated has a-series of annular piston rings 16 molded into the interior portion surface of the aperture 14.
  • the tip 10 further includes a loop 18 which is preferably a thread of a material which is inert in uterine fluids, such as nylon.
  • the apparatus 20 shown in FIG. 1 is specifically designed for use in the method of this invention.
  • the apparatus 20 includes a tubular extension 22, a dispensing apparatus 24, and a control handle 26 for both operating the dispensing means and positioning the tip 10 on the end of the tubular extension 22.
  • the tubular extension 22 has a rigid section which is adjacent to the control handle 26.
  • the opposite terminal end portion 28 on which the tip 10 is secured is flexible.
  • One end of each control wire 30, 32 is attached to the end portion of the flexible section 28.
  • the control wires 30, 32 are connected at their opposite ends to a pair of separately controlled drums 34 (only one drum is shown) mounted on the control hand 26. By adjustment of the drums 34 to either to collect or release the wires 30, 32 the position of the tip 10 can be adjusted and bent in a curved configuration shown in FIG. 2.
  • a metal connector 36 ' is provided which has annular piston ring 38 which mates with the piston rings 16 on the tip 10.
  • the metal connector '36 further has defined in it a constricted area having a sharp cut off portion 40.
  • a tube 42 extends from the dispensing means 24, through the tubular extension 22 to the aperture 14 in the tip 10.
  • the dispensing means 24 consists of a mixing syringe 44 in which the plunger 46 is adapted to provide mixing of a fluid elastermeric material, a catalyst and other additive as may be required.
  • the syringe 44 is mounted on top of the control handle 26 with the plunger 46 in contact with a rack 48 and a pivotal mounted pawl 50.
  • the pawl 50 is connected to a trigger 52. Squeezing the trigger 52 causes the plunger 46 to be advanced within the syringe 46 and material within thesyringe 44 to be dispensed through the tube 42 to the tip 10.
  • the tip 10 is inserted over the end of the flexible portion 28 of the tubular extension.
  • the tip 10 being premolded of asilicone rubher is somewhat elastic and deforms somewhat until the piston ring 16 of the tip of 10 engages and locks with the mating piston rings 38.
  • the tubular extension 20 with tip 10 installed is inserted into the vagina 54, through the cervical os 56 into the uterine cavity 58. Then, preferably using flouroscopic techniques, the tip 10 is aligned with the uterine end of one of the oviducts 12. It should be noted that because of the shape of the uterine cavity 58 thetip can be guided blindly in the proper position. The relative position of the flexible end 28 is controlled by adjustment of the drums 34.
  • the fluid mixture of the elastomer, catalyst and other additives are injected through the tube 42 to the tip 10 by operation of the trigger 52 as noted above.
  • the uncured fluid elastomeric mixture 60 flows through the aperture 14 in the tip 10 and then into the oviduct 12.
  • a sufficient amount of the mixture is injected to fill approximately one third or more of the length of the oviduct 12.
  • Some of the material will flow back around the tip 10 so that the surface of the tip 10 will conform to the shape of the uterine end of the oviduct 12 as shown in the tip 10 as modified 62 which is shown in FIG. 5.
  • the solidified oviduct blocks each has a configuration which conforms to the interior of the oviduct in which it is cast, thus effectively preventing conception.
  • the oviduct block can remain in place until it is desired to remove it.
  • the use of a material having approximately the same modulus of elasticity as the oviducts assists in maintaining the oviduct blocks 64 in position.
  • the natural convolution of the oviduct likewise results in stabilization of the oviduct blocks 64.
  • the tip 10 serves a most important function of preventing the oviduct block 64 from migrating into the intraperitoneal cavity, a problem that was a serious and relatively common problem with othersimilar prior art technique.
  • the oviduct block is inserted nonsurgically.
  • the method is relatively simple to learn by those skilled in the medical art.
  • the time required is likewise quite short with a skilled person being able to block both oviducts in about 15 to 30 minutes.
  • the oviduct block can be removed nonsurgically if desired.
  • An instrument of the type shown in FIG. 1 is used for this purpose.
  • the tip 10 is replaced with a hooked member which is adapted to engage the loop 18. Once the loop 18 is engaged the oviduct block 64 is withdrawn. It is also possible to use a pronged member to grip the tip and then pull out the oviduct block.
  • Both the insertion and removal of the oviduct block 64 are relatively painless. However a local anesthetic can be used if desired.
  • the effectiveness of the contraception method of this invention was found to be excellent. On rabbit tests it was found that the method is 100% effective if the oviduct blocks are properly placed. In further rabbit tests it was found that after the oviduct blocks were removed that fertility was restored. There was no indication of explusion of the oviduct blocks either in the uterine cavity or in the int'raperitoneal cavity. Histologic examv, ination and scanning election microscopic examination have not indicated that there is any adverse reaction to the tissue of the oviducts.
  • control handle 26 has been provided to sisting of the trigger 52, rack 48 and pawl 50, could likewise be removed and the syringe operated manually.
  • configuration of the tip 10 can be modified to a different shape such as a conical configuration of other suitable shapes and still be satisfactory for use in this invention.
  • I claim: 1. The method of forming non-surgically removable oviduct block in a female comprising the step of a. providing a shaped tip member having an aperture defined therein; said tip memlber having a configuration such as to fit in substantial sealing contact adjacent to the uterine end of the oviduct of said female, and having a size larger than the lumen of said oviduct; said tip member being formed from a given cured elastomeric material b. positioning said tip member within the uterine cavity of said female adjacent to the uterine end of said oviduct with the aperture of said tip member being in axial alignment with the lumen of said oviduct c.
  • said tip member further includes a loop member whereby said loop member can be gripped to non-surgically remove said oviduct block.
  • the apparatus for forming the oviduct block according to claim 1, said apparatus comprising: a tubular means of a length sufficient to extend from vagina area of said female to the uterine ends of said oviducts and having a diameter sufficiently small to pass through the cervix of said female; said tubular means having first and second terminal ends; said first terminal end having an apertured tip member detachably connected thereto and also means for releaseably holding and ejecting said tip member, said tubular member including means for positioning said first terminal end with said tip member thereon adjacent the uterine end of said oviduct, and said tubular member further including means for transmission of said self curing elastomeric material from a point adjacent to the second terminal end toand through said aperture in said 'tip member secured to the first terminal end.
  • dispensing means is a syringe having a barrel and a plunger and wherein the plunger is advanceable within the barrel by a rack and paw] drive operated from the second terminal end.

Abstract

A method and apparatus is provided for non-surgical reversible sterilization of females. In the method of this invention an apparatus to which a removable tip is attached is inserted into the uterus. The tip is aligned with the uterine end of the oviduct. A curable elastomeric composition is injected, through an aperture in the tip, into the oviduct in an amount sufficient to fill the portion of the oviduct adjacent to the uterus. The elastomeric composition is allowed to solidify and adhere to the above noted tip. The apparatus is then removed with the tip being ejected from the apparatus so as to remain adhered to the resulting oviduct block. The above procedure is repeated for the opposite oviduct. The resulting oviduct blocks prevent the passage of ovum from the ovaries to the uterus and sperm from entering the oviduct thereby preventing conception. The oviduct blocks if desired can be removed non-surgically by utilizing an apparatus which grips the tip portion of the oviduct block and extracts the entire oviduct block from the oviduct.

Description

United States Patent [191 Erb [1111 3,805,767 [451 Apr. 23, 1974 22 Filed:
[ METHOD AND APPARATUS FOR NON-SURGICAL, REVERSIBLE STERILIZATION OF FEMALES [76'1" liiviitdif Robert Allan Erb, PO. Box 86,
Valley Forge, Pa. 19481 4 Feb. 26, 1973 [21] Appl. No.: 335,816
[52] U.S. Cl....' 128/1 R, 128/130, 128/303 R [51] Int. Cl A6lb 19/00 [58] Field of Search 128/1 R, 2 R, 130, 303 R [56] References Cited UNITED STATES PATENTS 3.042.030 7/1962 Read ....'.1.2s/130x Cook et a1. 128/2 R Primary ExaminerDa1ton Truluck Attorney, Agent, or Firm-Edward J. Sites [57] ABSTRACT A method and apparatus is provided for non-surgical reversible sterilization of females. In the method of this invention an apparatus to which a removable tip is attached is inserted into the uterus. The tip is, aligned with the uterine end of the oviduct. A curable elastomeric composition is injected, through an aperture in the tip, into the oviduct in an amount sufficient to fill the portion of the oviduct adjacent to the uterus. The elastomeric composition is allowed to solidify and adhere to the above noted tip. The apparatus is then removed with the tip being ejected from the apparatus so as to remain adhered to the resulting oviduct block. The above procedure is repeated. for the opposite oviduct. The resulting oviduct blocks prevent the passage of ovum from the ovaries to the uterus and sperm from entering'the oviduct thereby preventing conception. The oviduct blocks if desired can be removed non-surgically by utilizing an apparatus whichgrips the tip portion of the oviduct block and extracts the entire oviduct block from the oviduct.
9 Claims, 5 Drawing Figures PATENTEDAPRB 1974 SHEET 1 [1F 2 METHOD AND APPARATUS FOR NON-SURGICAL, REVERSIBLE STERILIZATION OF FEMALES The invention described herein was reduced to practice in the course of work under a grant oraward from the Department of Health, Education and Welfare.
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is concerned with a method and apparatus for non-surgical, reversible sterilization of females.
2. Description of the Prior Art One of the more pressing problems which is encountered in the World today is that of over population. The problem of over population which has been a substantial problem for a considerable period of time in certain highly populated areas, such as Asia and the Indian Sub-Continent is now becoming a problem in less populated areas of the World such as Europe and the Americas. Over population results in such long range problems as pollution, famine and even war.
Birth control has been relied on as the principal means to control over-population. In the field of birth control the prevention of conception is considerably more acceptable for controlling population growth than abortion. However, the methods heretofore suggested for contraception have had certain inherent problems which limited the applicability and effectiveness,
The ideal contraception method should be 100 percent effective in preventing conception; should not rely on willpower; should not interfere with the satisfaction of sexual relationships, and should be low in cost taking into consideration the effective life of the contraceptive method. In addition the contraceptive method must not have any harmful psychological side effects. An extremely important feature of an ideal contraceptive method especially for family planning is that it be reversible so that it will be possible to have additional children if desired.
The most common methods of contraception which are currently employed on a mass scale each have certain inherent deficiencies which limit their usefulness. The use of such techniques and devices such as rhythm, withdrawal, condoms and diaphragms and vaginal foams all have been found to be highly unreliable. The more recently promoted methods such as intrauterine devices and use of contraceptive pills likewise have certain defects which limit their effectiveness. The intrauterine devices cannot be utilized by all females and there is some indication that they cause irritation and discomfort and are often rejected by females. The contraceptive pill cannot be utilized by many females due to incompatability with their normal hormone balance. Furthermore, the use of the pill has been found to increase the risks of certain carcigenic conditions.
There are currently two methods in wide use which are generally considered to be effective contraceptive methods. These are oviduct ligation for females and vasectomy for males In both these methods the ducts from the reproductive organs are severed and accordingly the contraceptive technique if properly performed and there is no natural regeneration are 100% effective. However, both methods have the defect that it is difficult, if not impossible, to reverse the procedure so as to restore the normal reproductive capacity.
It has been well established by gynecologists that a primary cause ofinfertility in females is blockage of the oviducts from the ovary to the uterus. The ovum when discharged from the ovaries is absorbed by the body and is prevented from coming in contact with the sperm and accordingly conception does occur. Females having this natural condition normally do not even realize it exists and do not suffer any adverse side effect besides being infertile. Having been made aware of this natural condition those skilled in the art have suggested artificial blocking of the oviduct to impart sterility.
It was reported by Corfman et al. in Obstetrices and Gynecology Vol. 27 No.6 pages 880-883 (June 1966) that various substances could be injected transcervically into the oviducts.
Hefnawi et al. Amr. J. Obst and Gynec, Vol. 99, No. 3 pages 421-427 (Oct. 1, 1967) reported attempts to block the oviducts by the injecting of medical grade elastomeric materials in the uncured state into the ovi ducts and allowing the material to solidify in the oviducts. The elastomeric material was thinned prior to injection so as to have a relatively fluid mixture for injection. The reported results obtained with rabbits was quite unsatisfactory. The incidence of pregnancy'after insertion of the oviduct blocks was quite high. Effective sterilization was only achieved if the plug was placed in I the medial portion of the oviduct. To remove the plug it was necessary to conduct laparotomy'. A further problem which was reported was the tendency for the plug to migrate from the oviduct into either the uterine cavity or even more dangerously into the peritoneal cavity. 7
Rakshit reported in the Calcutta Med J 65, No. 3. (Mar., 1968) attempts to use various materials to block the oviducts to prevent conception. It was suggested to use a plastic material of a nature which solidifies after being mixed with a catalyst to form the oviduct blocks. Rakshit specifically taught however that because of high viscosity the silicone rubbers could not be injected transvaginally and laparotomies were conducted to inject the material directly into the uterus. The material was then allowed to flow into the oviducts. It was suggested in this article by Rakshit that it may be possible to introduce a plastic material transcervically into the uterus and then to allow it to flow in the oviducts. Using this method however the resulting oviduct blocks would have to be removed surgically to reestablish fertility.
Rakshit further reported in Human Sterilization edited by Ralph Rechart (l97l) pages 213-221 the technique of attempting to form oviduct blocks by inserting a cannula directly into the uterus through the cervix and filling the uterus witha curable liquid silicone plastic. The injected silicone plastic was allowed to flow into the oviducts and cure in place to form the desired oviduct blocks. The excess material was then removed from the uterus. The reported results were not promising. On tests reported on 14 women there were nine satisfactory blockages, three doubtful cases and two negative cases. Further, in orderto remove the oviduct blocks it was necessary to conduct a laparotorny.
SUMMARY OF THE INVENTION In accordance with this invention a method and apparatus is provided to form oviduct blocks which prevent conception when in place and can be nonsurgically removed if desires. The apparatus is inserted through the cervical os into the uterus. The tip on the apparatus is then aligned with the uterine end of the oviduct. A mixture of a fluid elastomeric material and a catalyst for polymerizing the elastomeric mixture is injected through an aperture in the tip into the oviduct. The elastomeric material is allowed to solidify and to adhere to the tip. The tip is released so that it remains with the injected elastomeric material to form the oviduct block of this invention. The apparatus is then removed. The oviduct block can be removed nonsurgically by inserting an instrument into the uterus through the cervix which grips the tip of the oviduct block and then withdrawing the oviduct block which restores normal fertility.
BRIEF DESCRIPTION OF THE DRAWING FIG. 1 is an illustration in partial cross-section of an apparatus especially adopted for use in the method of this invention.
FIG. 2 is an illustration in partial cross-section of a uterus, the cervix and a portion of the vagina. The uterus is illustrated with an oviduct block insert in one of the oviduct and the terminal end of the apparatus of FIG. 1 positioned for insertion of an oviduct block into the opposite oviduct.
FIG. 3 is an enlarged illustration taken in partial cross-section of the terminal end of the apparatus of FIG. 1.
FIG. 4 is an illustration in cross-section of the terminal end of the apparatus of FIG. 3 shown with fluid uncured elastomeric material shown in the internal feed tube.
FIG. 5 is an illustration shown in cross-section showing the separation of the tip from the apparatus of FIG. 1.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In the method of this invention an oviduct block is formed in situ in the oviduct. The oviduct block is most preferable formed from a medical inert plastic which has approximately the same modulus of elasticity as the oviduct. The selection of material having the proper modulus of elasticity appears to both' prevent cxplusion of the oviduct block and substantially eliminates any physical discomfort. The materials which have been found most useful in the method of this invention are the commercially available medical grade silicone elastomers. The uncured silicone elastomer in the fluid state is blended with a catalyst for solidifying the elastomer and a dilution fluid to control the viscosity during injection and also to control the modulus of elasticity of the cured solidified material. It is preferable to also include a radiopaque material in the mixture to facilitate the placement of the oviduct block and to facilitate removal of the oviduct block if desires.
A tip is molded from an inert plastic material to which the injected elastomeric material will adhere on solidification. In this regard it should be noted that silicone-rubber is ideally suited for this purpose when a silicone elastomer is used for formation of the oviduct block. I
As shown in the drawing the portion of the tip 10 which will be in contact with uterine end of the oviduct 12 has a spherical configuration. The tip 10 has an aperture 14 which extends throughout the entire length of the tip 14. In addition the tip as illustrated has a-series of annular piston rings 16 molded into the interior portion surface of the aperture 14. The tip 10 further includes a loop 18 which is preferably a thread of a material which is inert in uterine fluids, such as nylon.
The apparatus 20 shown in FIG. 1 is specifically designed for use in the method of this invention. The apparatus 20 includes a tubular extension 22, a dispensing apparatus 24, and a control handle 26 for both operating the dispensing means and positioning the tip 10 on the end of the tubular extension 22.
The tubular extension 22 has a rigid section which is adjacent to the control handle 26. The opposite terminal end portion 28 on which the tip 10 is secured is flexible. One end of each control wire 30, 32 is attached to the end portion of the flexible section 28. The control wires 30, 32 are connected at their opposite ends to a pair of separately controlled drums 34 (only one drum is shown) mounted on the control hand 26. By adjustment of the drums 34 to either to collect or release the wires 30, 32 the position of the tip 10 can be adjusted and bent in a curved configuration shown in FIG. 2.
At the flexible terminal end 28 a metal connector 36 'is provided which has annular piston ring 38 which mates with the piston rings 16 on the tip 10. The metal connector '36 further has defined in it a constricted area having a sharp cut off portion 40.
A tube 42 extends from the dispensing means 24, through the tubular extension 22 to the aperture 14 in the tip 10.
The dispensing means 24 consists of a mixing syringe 44 in which the plunger 46 is adapted to provide mixing of a fluid elastermeric material, a catalyst and other additive as may be required. The syringe 44 is mounted on top of the control handle 26 with the plunger 46 in contact with a rack 48 and a pivotal mounted pawl 50. The pawl 50 is connected to a trigger 52. Squeezing the trigger 52 causes the plunger 46 to be advanced within the syringe 46 and material within thesyringe 44 to be dispensed through the tube 42 to the tip 10.
In the method of this invention the tip 10 is inserted over the end of the flexible portion 28 of the tubular extension. The tip 10 being premolded of asilicone rubher is somewhat elastic and deforms somewhat until the piston ring 16 of the tip of 10 engages and locks with the mating piston rings 38.
The tubular extension 20 with tip 10 installed is inserted into the vagina 54, through the cervical os 56 into the uterine cavity 58. Then, preferably using flouroscopic techniques, the tip 10 is aligned with the uterine end of one of the oviducts 12. It should be noted that because of the shape of the uterine cavity 58 thetip can be guided blindly in the proper position. The relative position of the flexible end 28 is controlled by adjustment of the drums 34.
Once the tip 10 is in position the fluid mixture of the elastomer, catalyst and other additives are injected through the tube 42 to the tip 10 by operation of the trigger 52 as noted above. The uncured fluid elastomeric mixture 60 flows through the aperture 14 in the tip 10 and then into the oviduct 12. A sufficient amount of the mixture is injected to fill approximately one third or more of the length of the oviduct 12. Some of the material will flow back around the tip 10 so that the surface of the tip 10 will conform to the shape of the uterine end of the oviduct 12 as shown in the tip 10 as modified 62 which is shown in FIG. 5.
stripped from the terminal end as shown in phantom in FIG. 5.
The procedure noted above is repeated for the opposite oviduct to complete the sterilization procedure.
The solidified oviduct blocks each has a configuration which conforms to the interior of the oviduct in which it is cast, thus effectively preventing conception.
The oviduct block can remain in place until it is desired to remove it. The use of a material having approximately the same modulus of elasticity as the oviducts assists in maintaining the oviduct blocks 64 in position. The natural convolution of the oviduct likewise results in stabilization of the oviduct blocks 64. The tip 10 serves a most important function of preventing the oviduct block 64 from migrating into the intraperitoneal cavity, a problem that was a serious and relatively common problem with othersimilar prior art technique.
As noted above the oviduct block is inserted nonsurgically. The method is relatively simple to learn by those skilled in the medical art. The time required is likewise quite short with a skilled person being able to block both oviducts in about 15 to 30 minutes.
As noted above the oviduct block can be removed nonsurgically if desired. An instrument of the type shown in FIG. 1 is used for this purpose. The tip 10 is replaced with a hooked member which is adapted to engage the loop 18. Once the loop 18 is engaged the oviduct block 64 is withdrawn. It is also possible to use a pronged member to grip the tip and then pull out the oviduct block.
Both the insertion and removal of the oviduct block 64 are relatively painless. However a local anesthetic can be used if desired.
The effectiveness of the contraception method of this invention was found to be excellent. On rabbit tests it was found that the method is 100% effective if the oviduct blocks are properly placed. In further rabbit tests it was found that after the oviduct blocks were removed that fertility was restored. There was no indication of explusion of the oviduct blocks either in the uterine cavity or in the int'raperitoneal cavity. Histologic examv, ination and scanning election microscopic examination have not indicated that there is any adverse reaction to the tissue of the oviducts.
The apparatus of this invention has been described in preferred embodiment. It should be appreciated that the various modifications can be made. to the apparatus without departing from'the scope of this invention. For
example, the control handle 26 has been provided to sisting of the trigger 52, rack 48 and pawl 50, could likewise be removed and the syringe operated manually. Furthermore, the configuration of the tip 10 can be modified to a different shape such as a conical configuration of other suitable shapes and still be satisfactory for use in this invention. These and other modifications which would be obvious to those skilled in the art are included within the scope of the subjoined claims.
I claim: 1. The method of forming non-surgically removable oviduct block in a female comprising the step of a. providing a shaped tip member having an aperture defined therein; said tip memlber having a configuration such as to fit in substantial sealing contact adjacent to the uterine end of the oviduct of said female, and having a size larger than the lumen of said oviduct; said tip member being formed from a given cured elastomeric material b. positioning said tip member within the uterine cavity of said female adjacent to the uterine end of said oviduct with the aperture of said tip member being in axial alignment with the lumen of said oviduct c. injecting through the aperture of said tip member into the lumen of said oviduct a mixture of a fluid self curing elastomeric material which will solidify in said oviduct and adhere to said tip member, said elastomeric material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity d. and thereafter allowing said uncured elastomeric material to cure to a solidified mass while in contact with said tip member whereby an oviduct block is formed wherein the tip member remains within the uterine cavity where it can be gripped by mechanical means to remove the oviduct block non-surgically.
2. The method according to claim 1 wherein said tip member further includes a loop member whereby said loop member can be gripped to non-surgically remove said oviduct block.
3. The method according to claim 1 wherein said selfcuring elastomeric material is a self-curing silicone elastomer. y
4. The method according to claim 1 wherein said selfcuring elastomeric material when solidified has a modulus of elasticity substantially the same as said oviduct.
5. The apparatus for forming the oviduct block according to claim 1, said apparatus comprising: a tubular means of a length sufficient to extend from vagina area of said female to the uterine ends of said oviducts and having a diameter sufficiently small to pass through the cervix of said female; said tubular means having first and second terminal ends; said first terminal end having an apertured tip member detachably connected thereto and also means for releaseably holding and ejecting said tip member, said tubular member including means for positioning said first terminal end with said tip member thereon adjacent the uterine end of said oviduct, and said tubular member further including means for transmission of said self curing elastomeric material from a point adjacent to the second terminal end toand through said aperture in said 'tip member secured to the first terminal end.
6. The apparatus of claim 5 in which the first terminal end portion is flexible. 1
7. The apparatus according to claim 5 in which the position of the first terminal end is controlled by means operable from the second terminal end.
from said slideable member.
9. The apparatus according to claim 5 wherein the dispensing means is a syringe having a barrel and a plunger and wherein the plunger is advanceable within the barrel by a rack and paw] drive operated from the second terminal end.

Claims (9)

1. The method of forming non-surgically removable oviduct block in a female comprising the step of a. providing a shaped tip member having an aperture defined therein; said tip member having a configuration such as to fit in substantial sealing contact adjacent to the uterine end of the oviduct of said female, and having a size larger than the lumen of said oviduct; said tip member being formed from a given cured elastomeric material b. positioning said tip member within the uterine cavity of said female adjacent to the uterine end of said oviduct with the aperture of said tip member being in axial alignment with the lumen of said oviduct c. injecting through the aperture of said tip member into the lumen of said oviduct a mixture of a fluid self curing elastomeric material which will solidify in said oviduct and adhere to said tip member, said elastomeric material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity d. and thereafter allowing said uncured elastomeric material to cure to a solidified maSs while in contact with said tip member, whereby an oviduct block is formed wherein the tip member remains within the uterine cavity where it can be gripped by mechanical means to remove the oviduct block nonsurgically.
2. The method according to claim 1 wherein said tip member further includes a loop member whereby said loop member can be gripped to non-surgically remove said oviduct block.
3. The method according to claim 1 wherein said self-curing elastomeric material is a self-curing silicone elastomer.
4. The method according to claim 1 wherein said self-curing elastomeric material when solidified has a modulus of elasticity substantially the same as said oviduct.
5. The apparatus for forming the oviduct block according to claim 1, said apparatus comprising: a tubular means of a length sufficient to extend from vagina area of said female to the uterine ends of said oviducts and having a diameter sufficiently small to pass through the cervix of said female; said tubular means having first and second terminal ends; said first terminal end having an apertured tip member detachably connected thereto and also means for releaseably holding and ejecting said tip member, said tubular member including means for positioning said first terminal end with said tip member thereon adjacent the uterine end of said oviduct, and said tubular member further including means for transmission of said self curing elastomeric material from a point adjacent to the second terminal end to and through said aperture in said tip member secured to the first terminal end.
6. The apparatus of claim 5 in which the first terminal end portion is flexible.
7. The apparatus according to claim 5 in which the position of the first terminal end is controlled by means operable from the second terminal end.
8. The apparatus according to claim 5 wherein the means for holding and ejecting said tip member comprises a slideable member positioned within said tubular member whereby when a tip member is secured at the first terminal end to said slideable member and said slideable member is drawn through said tubular member toward the second terminal end said tip is removed from said slideable member.
9. The apparatus according to claim 5 wherein the dispensing means is a syringe having a barrel and a plunger and wherein the plunger is advanceable within the barrel by a rack and pawl drive operated from the second terminal end.
US00335816A 1973-02-26 1973-02-26 Method and apparatus for non-surgical, reversible sterilization of females Expired - Lifetime US3805767A (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
US00335816A US3805767A (en) 1973-02-26 1973-02-26 Method and apparatus for non-surgical, reversible sterilization of females
ZA740931A ZA74931B (en) 1973-02-26 1974-02-12 Method and apparatus for non-surgical,reversible sterilization of females
IL44203A IL44203A (en) 1973-02-26 1974-02-14 Apparatus for non-surgical reversible sterilization of females
DE19742407652 DE2407652C3 (en) 1973-02-26 1974-02-18 Non-surgically removable fallopian tube obstruction and device for its introduction
SE7402428A SE419698B (en) 1973-02-26 1974-02-22 MEANING AN APPLIANCE MANIPULATIVE DEVICE FOR ASTAD ACCOMPANYING A EGG BLOCK AND DEVICE MANIPULATING DEVICE
BR741387A BR7401387D0 (en) 1973-02-26 1974-02-22 PROCESS FOR THE APPLICATION OF A FEMALE ANTICONCEPTIONAL DEVICE AND THEIR DEVICE
GB825174A GB1430045A (en) 1973-02-26 1974-02-22 Contraceptive apparatus and method
IT48696/74A IT1015818B (en) 1973-02-26 1974-02-25 EQUIPMENT FOR THE REVERSIBLE NON-SURGICAL STERILIZATION OF FEMALES
NL747402502A NL154660B (en) 1973-02-26 1974-02-25 DEVICE FOR INSERTING A BLOCKING AGENT INTO AN EGG LINE.
BE141359A BE811539A (en) 1973-02-26 1974-02-25 CONTRACEPTION APPARATUS AND METHOD
JP49022743A JPS5239595B2 (en) 1973-02-26 1974-02-25
CA193,336A CA1046372A (en) 1973-02-26 1974-02-25 Method and apparatus for non-surgical reversible sterilization of females
FR7406289A FR2218907B1 (en) 1973-02-26 1974-02-25
CH270874A CH578876A5 (en) 1973-02-26 1974-02-26
AU66031/74A AU465515B2 (en) 1973-02-26 1974-02-26 Method and apparatus for nonsurgical reversible sterilization of females
US05/679,185 USRE29345E (en) 1973-02-26 1976-04-22 Method and apparatus for non-surgical, reversible sterilization of females
CA313,134A CA1062110A (en) 1973-02-26 1978-10-11 Method and apparatus for non-surgical, reversible sterilization of females

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00335816A US3805767A (en) 1973-02-26 1973-02-26 Method and apparatus for non-surgical, reversible sterilization of females

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US05/679,185 Reissue USRE29345E (en) 1973-02-26 1976-04-22 Method and apparatus for non-surgical, reversible sterilization of females

Publications (1)

Publication Number Publication Date
US3805767A true US3805767A (en) 1974-04-23

Family

ID=23313333

Family Applications (1)

Application Number Title Priority Date Filing Date
US00335816A Expired - Lifetime US3805767A (en) 1973-02-26 1973-02-26 Method and apparatus for non-surgical, reversible sterilization of females

Country Status (14)

Country Link
US (1) US3805767A (en)
JP (1) JPS5239595B2 (en)
AU (1) AU465515B2 (en)
BE (1) BE811539A (en)
BR (1) BR7401387D0 (en)
CA (1) CA1046372A (en)
CH (1) CH578876A5 (en)
FR (1) FR2218907B1 (en)
GB (1) GB1430045A (en)
IL (1) IL44203A (en)
IT (1) IT1015818B (en)
NL (1) NL154660B (en)
SE (1) SE419698B (en)
ZA (1) ZA74931B (en)

Cited By (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871374A (en) * 1973-09-06 1975-03-18 Population Res Inc Dispensing instrument
US3875939A (en) * 1974-01-31 1975-04-08 Population Res Inc Single stroke dispensing method
US3918431A (en) * 1974-01-11 1975-11-11 Manfred Sinnreich Fallopian tube obturating device
US3948259A (en) * 1973-03-09 1976-04-06 Population Research Incorporated Dispensing instrument
US3972331A (en) * 1973-03-09 1976-08-03 Population Research Incorporated Dispensing catheter
DE2411242C3 (en) 1973-03-09 1980-01-31 Population Research Inc., Minneapolis, Minn. (V.St.A.) Instrument for introducing substances into the fallopian tubes
EP0010812A1 (en) * 1978-10-26 1980-05-14 Karel Johan Hendrik Verschoof Contraceptive device
US4245623A (en) * 1978-06-06 1981-01-20 Erb Robert A Method and apparatus for the hysteroscopic non-surgical sterilization of females
US4271845A (en) * 1978-07-01 1981-06-09 Kabushiki Kaisha Medos Kenkyusho Device for bending a medical instrument inserted into the body cavity
US4273131A (en) * 1979-06-18 1981-06-16 Auburn Enterprises, Inc. Surgical stylet
US4363318A (en) * 1979-12-31 1982-12-14 University Patents, Inc. Custom valved cervical cap
US4365632A (en) * 1978-05-05 1982-12-28 Kortum William M Method and apparatus for inducing immunological and resistant response in mammary glands
US4446578A (en) * 1982-03-08 1984-05-08 Perkins Ezra C Joint treatment
US4601698A (en) * 1984-09-17 1986-07-22 Moulding Jr Thomas S Method of and instrument for injecting a fluid into a uterine cavity and for dispersing the fluid into the fallopian tubes
US4637818A (en) * 1983-11-25 1987-01-20 Johnson Richard K Apparatus for producing sterility in female animals
US4700701A (en) * 1985-10-23 1987-10-20 Montaldi David H Sterilization method and apparatus
US4805618A (en) * 1985-08-08 1989-02-21 Olympus Optical Co., Ltd. Oviduct closing apparatus
US5217466A (en) * 1991-04-19 1993-06-08 Hasson Harrith M Guide for facilitating the performance of internal surgery
US5342394A (en) * 1990-05-16 1994-08-30 Olympus Optical Co., Ltd. Apparatus for blocking a vein branch and method of blocking a vein branch
US5368598A (en) * 1991-04-19 1994-11-29 Hasson; Harrith M. Method of manipulating an uterus using a bendable manipulator
US5555896A (en) * 1994-09-26 1996-09-17 Cimber; Hugo Intrauterine contraceptive device
WO1996040024A1 (en) * 1995-06-07 1996-12-19 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
WO1996040023A1 (en) * 1995-06-07 1996-12-19 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US5795353A (en) * 1994-05-06 1998-08-18 Advanced Bio Surfaces, Inc. Joint resurfacing system
WO1998055046A1 (en) 1997-06-05 1998-12-10 Adiana, Inc. Method and apparatus for tubal occlusion
EP0891757A2 (en) * 1997-07-18 1999-01-20 Gynecare, Inc. Tubular fallopian sterilization device
WO1999015116A1 (en) 1997-09-24 1999-04-01 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
WO2000033724A2 (en) * 1998-12-08 2000-06-15 Hysterx, Inc. Devices and methods for occlusion of the uterine arteries
US20030195628A1 (en) * 1994-05-06 2003-10-16 Qi-Bin Bao Method of making an intervertebral disc prosthesis
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US6712810B2 (en) 1999-02-01 2004-03-30 Adiana, Inc. Method and apparatus for tubal occlusion
US6763833B1 (en) 1999-08-23 2004-07-20 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US20050033281A1 (en) * 2002-05-23 2005-02-10 Adiana, Inc. Catheter placement detection system and operator interface
US20050061329A1 (en) * 2003-09-18 2005-03-24 Conceptus, Inc. Catheter for intrafallopian contraceptive delivery
US20050148995A1 (en) * 2003-12-29 2005-07-07 Kimberly-Clark Worldwide, Inc. Anatomically conforming vaginal insert
US20070023534A1 (en) * 2005-07-22 2007-02-01 Mingsheng Liu Water-source heat pump control system and method
US20070261699A1 (en) * 2006-05-11 2007-11-15 Callister Jeffrey P Methods and Apparatus for Occluding Reproductive Tracts to Effect Contraception
US20080047563A1 (en) * 2005-02-15 2008-02-28 Tal Michael G Intrauterine fallopian tube occlusion device
US20090036840A1 (en) * 2006-11-22 2009-02-05 Cytyc Corporation Atraumatic ball tip and side wall opening
US20090056722A1 (en) * 2007-08-28 2009-03-05 Betsy Swann Methods and devices for occluding an ovarian pathway
US20090125023A1 (en) * 2007-11-13 2009-05-14 Cytyc Corporation Electrosurgical Instrument
US20090178682A1 (en) * 2005-02-15 2009-07-16 Tal Michael G Intrauterine fallopian tube occlusion device
US20100063360A1 (en) * 2006-11-28 2010-03-11 Adiana, Inc. Side-arm Port Introducer
US20100086492A1 (en) * 2008-10-03 2010-04-08 Kathy Lee-Sepsick Methods and devices for sonographic imaging
US20100094074A1 (en) * 2008-10-10 2010-04-15 Hologic Inc. Brachytherapy apparatus and methods employing expandable medical devices comprising fixation elements
US20110125158A1 (en) * 2008-05-01 2011-05-26 Ashish Dhar Diwan Systems, methods and apparatuses for formation and insertion of tissue prostheses
US20110180073A1 (en) * 2010-01-22 2011-07-28 David Callaghan Sterilization Device and Method
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8550086B2 (en) 2010-05-04 2013-10-08 Hologic, Inc. Radiopaque implant
US8662081B2 (en) 2005-02-15 2014-03-04 Yale University Intrauterine device
US8702727B1 (en) 1999-02-01 2014-04-22 Hologic, Inc. Delivery catheter with implant ejection mechanism
US8851077B2 (en) 2007-03-19 2014-10-07 Hologic, Inc. Methods and apparatus for occlusion of body lumens
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
US9017351B2 (en) 2010-06-29 2015-04-28 Artventive Medical Group, Inc. Reducing flow through a tubular structure
US9060773B2 (en) 2011-12-16 2015-06-23 Covidien Lp Occlusive implant delivery devices and associated methods
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
EP2904998A1 (en) * 2012-04-24 2015-08-12 Urogyn B.V. Occluding compound for a fallopian tube
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9180039B2 (en) 2010-08-16 2015-11-10 Yale University Intrauterine device
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL185264C (en) * 1978-01-27 1990-03-01 Medline Ab Means for at least temporarily blocking channels or hollow spaces in humans or animals.
GB2150032B (en) * 1983-11-25 1988-01-06 Richard K Johnson Method of producing sterility in female animals
EP1554999B1 (en) * 1999-08-23 2008-01-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
AT503419B1 (en) * 2006-06-08 2007-10-15 Hans-Peter Dr Steiner Dosing device for uterine embryo transfer, has trigger unit supporting rotary motions in both directions of rotation, activating pressure and/or suction movements of syringe piston, and comprising opening for finger that operates unit

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042030A (en) * 1958-11-25 1962-07-03 Read Thane Spherical type insert plug for body passageway and tool therefor
US3182662A (en) * 1962-07-25 1965-05-11 Vithal N Shirodkar Plastic prosthesis useful in gynaecological surgery
US3422813A (en) * 1965-06-21 1969-01-21 Dow Corning Method for sterilization of males
US3648683A (en) * 1970-06-29 1972-03-14 Nathan Brodie Reversible intra-vas device
US3680542A (en) * 1970-05-11 1972-08-01 Hugo S Cimber Device for occlusion of an oviduct
US3707146A (en) * 1967-03-07 1972-12-26 Prod Res & Chem Corp Means to inject a plastic into a cavity to produce a replica thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042030A (en) * 1958-11-25 1962-07-03 Read Thane Spherical type insert plug for body passageway and tool therefor
US3182662A (en) * 1962-07-25 1965-05-11 Vithal N Shirodkar Plastic prosthesis useful in gynaecological surgery
US3422813A (en) * 1965-06-21 1969-01-21 Dow Corning Method for sterilization of males
US3707146A (en) * 1967-03-07 1972-12-26 Prod Res & Chem Corp Means to inject a plastic into a cavity to produce a replica thereof
US3680542A (en) * 1970-05-11 1972-08-01 Hugo S Cimber Device for occlusion of an oviduct
US3648683A (en) * 1970-06-29 1972-03-14 Nathan Brodie Reversible intra-vas device

Cited By (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948259A (en) * 1973-03-09 1976-04-06 Population Research Incorporated Dispensing instrument
US3972331A (en) * 1973-03-09 1976-08-03 Population Research Incorporated Dispensing catheter
DE2411242C3 (en) 1973-03-09 1980-01-31 Population Research Inc., Minneapolis, Minn. (V.St.A.) Instrument for introducing substances into the fallopian tubes
US3871374A (en) * 1973-09-06 1975-03-18 Population Res Inc Dispensing instrument
US3918431A (en) * 1974-01-11 1975-11-11 Manfred Sinnreich Fallopian tube obturating device
US3875939A (en) * 1974-01-31 1975-04-08 Population Res Inc Single stroke dispensing method
US4365632A (en) * 1978-05-05 1982-12-28 Kortum William M Method and apparatus for inducing immunological and resistant response in mammary glands
DK152407B (en) * 1978-06-06 1988-02-29 Ovabloc Inc METHOD AND APPARATUS FOR HYSTEROSCOPIC NON-SURGICAL STERILIZATION OF WOMEN
US4245623A (en) * 1978-06-06 1981-01-20 Erb Robert A Method and apparatus for the hysteroscopic non-surgical sterilization of females
US4271845A (en) * 1978-07-01 1981-06-09 Kabushiki Kaisha Medos Kenkyusho Device for bending a medical instrument inserted into the body cavity
EP0010812A1 (en) * 1978-10-26 1980-05-14 Karel Johan Hendrik Verschoof Contraceptive device
US4273131A (en) * 1979-06-18 1981-06-16 Auburn Enterprises, Inc. Surgical stylet
US4363318A (en) * 1979-12-31 1982-12-14 University Patents, Inc. Custom valved cervical cap
US4446578A (en) * 1982-03-08 1984-05-08 Perkins Ezra C Joint treatment
US4637818A (en) * 1983-11-25 1987-01-20 Johnson Richard K Apparatus for producing sterility in female animals
US4601698A (en) * 1984-09-17 1986-07-22 Moulding Jr Thomas S Method of and instrument for injecting a fluid into a uterine cavity and for dispersing the fluid into the fallopian tubes
US4805618A (en) * 1985-08-08 1989-02-21 Olympus Optical Co., Ltd. Oviduct closing apparatus
US4700701A (en) * 1985-10-23 1987-10-20 Montaldi David H Sterilization method and apparatus
US5342394A (en) * 1990-05-16 1994-08-30 Olympus Optical Co., Ltd. Apparatus for blocking a vein branch and method of blocking a vein branch
US5217466A (en) * 1991-04-19 1993-06-08 Hasson Harrith M Guide for facilitating the performance of internal surgery
US5368598A (en) * 1991-04-19 1994-11-29 Hasson; Harrith M. Method of manipulating an uterus using a bendable manipulator
US5795353A (en) * 1994-05-06 1998-08-18 Advanced Bio Surfaces, Inc. Joint resurfacing system
US7713301B2 (en) 1994-05-06 2010-05-11 Disc Dynamics, Inc. Intervertebral disc prosthesis
US7766965B2 (en) 1994-05-06 2010-08-03 Disc Dynamics, Inc. Method of making an intervertebral disc prosthesis
US20070038300A1 (en) * 1994-05-06 2007-02-15 Disc Dynamics, Inc. Intervertebral disc prosthesis
US7077865B2 (en) 1994-05-06 2006-07-18 Disc Dynamics, Inc. Method of making an intervertebral disc prosthesis
US7001431B2 (en) 1994-05-06 2006-02-21 Disc Dynamics, Inc. Intervertebral disc prosthesis
US20030195628A1 (en) * 1994-05-06 2003-10-16 Qi-Bin Bao Method of making an intervertebral disc prosthesis
US20030220649A1 (en) * 1994-05-06 2003-11-27 Qi-Bin Bao Intervertebral disc prosthesis
US5555896A (en) * 1994-09-26 1996-09-17 Cimber; Hugo Intrauterine contraceptive device
US6679266B2 (en) 1995-06-07 2004-01-20 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20070062542A1 (en) * 1995-06-07 2007-03-22 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US7686020B2 (en) 1995-06-07 2010-03-30 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
WO1996040024A1 (en) * 1995-06-07 1996-12-19 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
WO1996040023A1 (en) * 1995-06-07 1996-12-19 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6145505A (en) * 1995-06-07 2000-11-14 Conceptus, Inc. Electrically affixed transcervical fallopian tube occlusion devices
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US7428904B2 (en) 1995-06-07 2008-09-30 Alien Technology Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6526979B1 (en) 1995-06-07 2003-03-04 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
AU711768B2 (en) * 1995-06-07 1999-10-21 Bayer Essure Inc. Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
US6634361B1 (en) 1995-06-07 2003-10-21 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20110030696A1 (en) * 1995-06-07 2011-02-10 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
EP1366729A2 (en) * 1995-06-07 2003-12-03 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
EP1366729A3 (en) * 1995-06-07 2003-12-10 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
AU707047B2 (en) * 1995-06-07 1999-07-01 Bayer Essure Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6684884B2 (en) 1995-06-07 2004-02-03 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US7921848B2 (en) 1995-06-07 2011-04-12 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8066007B2 (en) 1995-06-07 2011-11-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20070144528A1 (en) * 1995-06-07 2007-06-28 Julian Nikolchev Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20040079377A1 (en) * 1995-06-07 2004-04-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20040127918A1 (en) * 1995-06-07 2004-07-01 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8733361B2 (en) 1995-06-07 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US20040159324A1 (en) * 1995-06-07 2004-08-19 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20040163651A1 (en) * 1995-06-07 2004-08-26 Conceptus, Inc. Transcervical fallopian tube occlusion devices and their delivery
US20070044808A1 (en) * 1995-06-07 2007-03-01 Conceptus, Inc., A California Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US8171936B2 (en) 1995-06-07 2012-05-08 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20040206358A1 (en) * 1995-06-07 2004-10-21 Conceptus, Inc., A California Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20040211429A1 (en) * 1995-06-07 2004-10-28 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20070000496A1 (en) * 1995-06-07 2007-01-04 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US20060144406A1 (en) * 1995-06-07 2006-07-06 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US8356599B2 (en) 1995-06-07 2013-01-22 Conceptus, Inc. Occlusion devices and methods
US6871650B1 (en) * 1995-06-07 2005-03-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
EP1561427A1 (en) 1995-06-07 2005-08-10 Conceptus, Inc. Electrically expandable contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
US8327852B2 (en) 1995-06-07 2012-12-11 Conceptus, Inc. Occlusion devices and methods
US6726682B2 (en) 1997-06-05 2004-04-27 Adiana, Inc. Method and apparatus for tubal occlusion
US6068626A (en) * 1997-06-05 2000-05-30 Adiana, Inc. Method and apparatus for tubal occlusion
US6346102B1 (en) 1997-06-05 2002-02-12 Adiana, Inc. Method and apparatus for tubal occlusion
US5954715A (en) * 1997-06-05 1999-09-21 Adiana, Inc. Method and apparatus for tubal occlusion
US7905880B2 (en) 1997-06-05 2011-03-15 Cytyc Corporation Method and apparatus for tubal occlusion
US20040204720A1 (en) * 1997-06-05 2004-10-14 Adiana, Inc. Method and apparatus for tubal occlusion
WO1998055046A1 (en) 1997-06-05 1998-12-10 Adiana, Inc. Method and apparatus for tubal occlusion
US20070215163A1 (en) * 1997-06-05 2007-09-20 Adiana, Inc. Method and Apparatus for Tubal Occlusion
US7220259B2 (en) 1997-06-05 2007-05-22 Adiana, Inc. Method and apparatus for tubal occlusion
EP0891757A2 (en) * 1997-07-18 1999-01-20 Gynecare, Inc. Tubular fallopian sterilization device
EP0891757A3 (en) * 1997-07-18 1999-12-22 Gynecare, Inc. Tubular fallopian sterilization device
EP2260800A2 (en) 1997-09-24 2010-12-15 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices
US8733360B2 (en) 1997-09-24 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US8613282B2 (en) 1997-09-24 2013-12-24 Conceptus, Inc. Occlusion devices and methods
WO1999015116A1 (en) 1997-09-24 1999-04-01 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
EP1541101A2 (en) 1997-09-24 2005-06-15 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices
US7771357B2 (en) 1998-12-08 2010-08-10 Vascular Control Systems, Inc. Devices and methods for occlusion of the uterine arteries
WO2000033724A3 (en) * 1998-12-08 2000-08-10 Hysterx Inc Devices and methods for occlusion of the uterine arteries
WO2000033724A2 (en) * 1998-12-08 2000-06-15 Hysterx, Inc. Devices and methods for occlusion of the uterine arteries
US6712810B2 (en) 1999-02-01 2004-03-30 Adiana, Inc. Method and apparatus for tubal occlusion
US8702727B1 (en) 1999-02-01 2014-04-22 Hologic, Inc. Delivery catheter with implant ejection mechanism
US20040255958A1 (en) * 1999-02-01 2004-12-23 Adiana, Inc. Method and apparatus for tubal occlusion
US7842035B2 (en) 1999-02-01 2010-11-30 Cytyc Corporation Method and apparatus for tubal occlusion
US8226645B2 (en) 1999-02-01 2012-07-24 Cytyc Corporation Apparatus for tubal occlusion
US20090277463A1 (en) * 1999-08-23 2009-11-12 Conceptus, Inc., A California Corporation Deployment Actuation System for Intrafallopian Contraception
US20040163650A1 (en) * 1999-08-23 2004-08-26 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US9597224B2 (en) 1999-08-23 2017-03-21 Bayer Healthcare Llc Deployment actuation system
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US6763833B1 (en) 1999-08-23 2004-07-20 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US7237552B2 (en) 1999-08-23 2007-07-03 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US7591268B2 (en) 1999-08-23 2009-09-22 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US7934504B2 (en) 1999-08-23 2011-05-03 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US8695604B2 (en) 1999-08-23 2014-04-15 Bayer Essure Inc. Deployment actuation system
US8079364B2 (en) 1999-08-23 2011-12-20 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US7506650B2 (en) 1999-08-23 2009-03-24 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US8584679B2 (en) 1999-08-23 2013-11-19 Conceptus, Inc. Deployment actuation system
US20050232961A1 (en) * 1999-08-23 2005-10-20 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US8381733B2 (en) 1999-08-23 2013-02-26 Conceptus, Inc. Deployment actuation system
US7582085B2 (en) 2002-05-23 2009-09-01 Cytyc Corporation Catheter placement detection system and operator interface
US20050033281A1 (en) * 2002-05-23 2005-02-10 Adiana, Inc. Catheter placement detection system and operator interface
US20050061329A1 (en) * 2003-09-18 2005-03-24 Conceptus, Inc. Catheter for intrafallopian contraceptive delivery
US20050148995A1 (en) * 2003-12-29 2005-07-07 Kimberly-Clark Worldwide, Inc. Anatomically conforming vaginal insert
US8506543B2 (en) 2003-12-29 2013-08-13 Kimberly-Clark Worldwide, Inc. Anatomically conforming vaginal insert
US8217219B2 (en) 2003-12-29 2012-07-10 Kimberly-Clark Worldwide, Inc. Anatomically conforming vaginal insert
US8726906B2 (en) 2004-02-25 2014-05-20 Femasys Inc. Methods and devices for conduit occlusion
US8695606B2 (en) 2004-02-25 2014-04-15 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US9839444B2 (en) 2004-02-25 2017-12-12 Femasys Inc. Methods and devices for conduit occlusion
US10111687B2 (en) 2004-02-25 2018-10-30 Femasys, Inc. Methods and devices for conduit occlusion
US10292732B2 (en) 2004-02-25 2019-05-21 Femasys, Inc. Methods and devices for conduit occlusion
US9402762B2 (en) 2004-02-25 2016-08-02 Femasys Inc. Methods and devices for conduit occlusion
US9308023B2 (en) 2004-02-25 2016-04-12 Femasys Inc. Methods and devices for conduit occlusion
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9220880B2 (en) 2004-02-25 2015-12-29 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8316854B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Methods and devices for conduit occlusion
US8316853B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Method and devices for conduit occlusion
US8324193B2 (en) 2004-02-25 2012-12-04 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8336552B2 (en) 2004-02-25 2012-12-25 Femasys Inc. Methods and devices for conduit occlusion
US9034053B2 (en) 2004-02-25 2015-05-19 Femasys Inc. Methods and devices for conduit occlusion
US11779372B2 (en) 2004-02-25 2023-10-10 Femasys Inc. Methods and devices for conduit occlusion
US20080047563A1 (en) * 2005-02-15 2008-02-28 Tal Michael G Intrauterine fallopian tube occlusion device
US20090178682A1 (en) * 2005-02-15 2009-07-16 Tal Michael G Intrauterine fallopian tube occlusion device
US20080178889A1 (en) * 2005-02-15 2008-07-31 Tal Michael G Intrauterine Fallopian Tube Occlusion Device and Method For Use
US7621276B2 (en) 2005-02-15 2009-11-24 Yale University Intrauterine fallopian tube occlusion device
US9510088B2 (en) 2005-02-15 2016-11-29 Yale University Intrauterine device
US8662081B2 (en) 2005-02-15 2014-03-04 Yale University Intrauterine device
US7669601B2 (en) 2005-02-15 2010-03-02 Tal Michael G Intrauterine fallopian tube occlusion device and method for use
US9016280B2 (en) 2005-02-15 2015-04-28 Yale University Intrauterine fallopian tube occlusion device
US8181653B2 (en) 2005-02-15 2012-05-22 Yale University Intrauterine fallopian tube occlusion device
US20070023534A1 (en) * 2005-07-22 2007-02-01 Mingsheng Liu Water-source heat pump control system and method
US9492291B2 (en) 2005-08-15 2016-11-15 Kunovus Pty Ltd. Systems, methods and apparatuses for formation and insertion of tissue prosthesis
US7975697B2 (en) 2006-05-11 2011-07-12 Conceptus, Inc. Methods and apparatus for occluding reproductive tracts to effect contraception
US8550085B2 (en) 2006-05-11 2013-10-08 Conceptus, Inc. Methods and apparatus for occluding reproductive tracts to effect contraception
US20070261699A1 (en) * 2006-05-11 2007-11-15 Callister Jeffrey P Methods and Apparatus for Occluding Reproductive Tracts to Effect Contraception
US20090036840A1 (en) * 2006-11-22 2009-02-05 Cytyc Corporation Atraumatic ball tip and side wall opening
US20100063360A1 (en) * 2006-11-28 2010-03-11 Adiana, Inc. Side-arm Port Introducer
US9707124B2 (en) 2007-03-19 2017-07-18 Hologic, Inc. Methods and apparatus for occlusion of body lumens
US8851077B2 (en) 2007-03-19 2014-10-07 Hologic, Inc. Methods and apparatus for occlusion of body lumens
US8100129B2 (en) 2007-08-28 2012-01-24 Conceptus, Inc. Methods and devices for occluding an ovarian pathway
US20090056722A1 (en) * 2007-08-28 2009-03-05 Betsy Swann Methods and devices for occluding an ovarian pathway
US8726905B2 (en) 2007-08-28 2014-05-20 Bayer Essure Inc. Methods and devices for occluding an ovarian pathway
US20090125023A1 (en) * 2007-11-13 2009-05-14 Cytyc Corporation Electrosurgical Instrument
US20110125158A1 (en) * 2008-05-01 2011-05-26 Ashish Dhar Diwan Systems, methods and apparatuses for formation and insertion of tissue prostheses
US20100086492A1 (en) * 2008-10-03 2010-04-08 Kathy Lee-Sepsick Methods and devices for sonographic imaging
US11648033B2 (en) 2008-10-03 2023-05-16 Femasys Inc. Methods and devices for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US10172643B2 (en) 2008-10-03 2019-01-08 Femasys, Inc. Contrast agent generation and injection system for sonographic imaging
US10258375B2 (en) 2008-10-03 2019-04-16 Femasys, Inc. Methods and devices for sonographic imaging
US11154326B2 (en) 2008-10-03 2021-10-26 Femasys Inc. Methods and devices for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US20100094074A1 (en) * 2008-10-10 2010-04-15 Hologic Inc. Brachytherapy apparatus and methods employing expandable medical devices comprising fixation elements
US20110180073A1 (en) * 2010-01-22 2011-07-28 David Callaghan Sterilization Device and Method
US8231619B2 (en) 2010-01-22 2012-07-31 Cytyc Corporation Sterilization device and method
US8550086B2 (en) 2010-05-04 2013-10-08 Hologic, Inc. Radiopaque implant
US9017351B2 (en) 2010-06-29 2015-04-28 Artventive Medical Group, Inc. Reducing flow through a tubular structure
US9451965B2 (en) 2010-06-29 2016-09-27 Artventive Medical Group, Inc. Reducing flow through a tubular structure
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US9492311B2 (en) 2010-08-16 2016-11-15 Yale University Intrauterine device
US9180039B2 (en) 2010-08-16 2015-11-10 Yale University Intrauterine device
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9060773B2 (en) 2011-12-16 2015-06-23 Covidien Lp Occlusive implant delivery devices and associated methods
EP2904998A1 (en) * 2012-04-24 2015-08-12 Urogyn B.V. Occluding compound for a fallopian tube
US9107669B2 (en) 2013-02-05 2015-08-18 Artventive Medical Group, Inc. Blood vessel occlusion
US9737307B2 (en) 2013-02-05 2017-08-22 Artventive Medical Group, Inc. Blood vessel occlusion
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
US10004513B2 (en) 2013-02-05 2018-06-26 Artventive Medical Group, Inc. Bodily lumen occlusion
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US10441290B2 (en) 2013-06-14 2019-10-15 Artventive Medical Group, Inc. Implantable luminal devices
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US11224438B2 (en) 2014-05-01 2022-01-18 Artventive Medical Group, Inc. Treatment of incompetent vessels
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system

Also Published As

Publication number Publication date
BE811539A (en) 1974-06-17
AU465515B2 (en) 1975-10-02
GB1430045A (en) 1976-03-31
DE2407652B2 (en) 1976-01-15
SE419698B (en) 1981-08-24
FR2218907A1 (en) 1974-09-20
DE2407652A1 (en) 1974-09-12
JPS5239595B2 (en) 1977-10-06
IT1015818B (en) 1977-05-20
FR2218907B1 (en) 1978-07-21
ZA74931B (en) 1974-12-24
IL44203A0 (en) 1974-05-16
CH578876A5 (en) 1976-08-31
NL7402502A (en) 1974-08-28
AU6603174A (en) 1975-08-28
CA1046372A (en) 1979-01-16
IL44203A (en) 1977-03-31
JPS49135486A (en) 1974-12-26
BR7401387D0 (en) 1974-11-05
NL154660B (en) 1977-10-17

Similar Documents

Publication Publication Date Title
US3805767A (en) Method and apparatus for non-surgical, reversible sterilization of females
USRE29345E (en) Method and apparatus for non-surgical, reversible sterilization of females
US11744728B2 (en) Intrauterine device with retrieval thread
US4245623A (en) Method and apparatus for the hysteroscopic non-surgical sterilization of females
CA2596300C (en) Intrauterine fallopian tube occlusion device and method for use
US3680542A (en) Device for occlusion of an oviduct
Yoon et al. A preliminary report on a new laparoscopic sterilization approach: the silicone rubber band technique
CA1062110A (en) Method and apparatus for non-surgical, reversible sterilization of females
Soichet Ypsilon: a new silicone-covered stainless steel intrauterine contraceptive device
Rashbaum et al. Immediate postpartum insertion of a new intrauterine contraceptive device
Reed III Hysteroscopic sterilization: silicone elastic plugs
DE2407652C3 (en) Non-surgically removable fallopian tube obstruction and device for its introduction
DUMESIC et al. A new approach to hysteroscopic cannulation of the fallopian tube
Solish New Stainless Steel Spring for Intrauterine Contraception
Wagner Diagnosis and treatment of complications of intrauterine contraceptive devices
IL286451A (en) Intrauterine 3-dimensional device and methods of use
Pendergrass et al. A technique for vaginal casting utilizing vinyl polysiloxane dental impression material
Sisa Double (uterine and ectopic) pregnancy of a patient using an intrauterine contraceptive device
CN115279312A (en) Inserter with locking part for intrauterine system
Wamsteker et al. Novel Techniques in Tubal Contraception
Bluett The Nova T Copper 200 Ag: a preliminary appraisal
CZ114496A3 (en) Apparatus for provoking increased intrauterine pressure
Buckett et al. Alternative assisted conception techniques
Masters et al. Insertion of the levonorgestrel intrauterine system (LNG-IUS) in post-menopausal women
SK134291A3 (en) The intrauterine contraceptive device with incidental elimination of menstrual pain

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED FILE - (OLD CASE ADDED FOR FILE TRACKING PURPOSES)

AS Assignment

Owner name: CALSPAN CORPORATION, 4455 GENESSE ST., BUFFALO, NY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:FRANKLIN INSTITUTE;REEL/FRAME:004379/0744

Effective date: 19850109

AS Assignment

Owner name: FRANKLIN INSTITUTE, 20TH STREET AND THE PARKWAY, P

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:CALSPAN CORPORATION, AN OH CORP.;REEL/FRAME:004747/0260

Effective date: 19860604

Owner name: FRANKLIN INSTITUTE, PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CALSPAN CORPORATION, AN OH CORP.;REEL/FRAME:004747/0260

Effective date: 19860604